Japan · Delayed Price · Currency is JPY Organo Statistics
Total Valuation
Organo has a market cap or net worth of JPY 731.81 billion. The enterprise value is 735.16 billion.
| Market Cap | 731.81B |
| Enterprise Value | 735.16B |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Organo has 45.98 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 45.98M |
| Shares Outstanding | 45.98M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 21.28% |
| Float | 24.62M |
Valuation Ratios
The trailing PE ratio is 25.76 and the forward PE ratio is 23.41.
| PE Ratio | 25.76 |
| Forward PE | 23.41 |
| PS Ratio | 4.12 |
| PB Ratio | 5.12 |
| P/TBV Ratio | 5.18 |
| P/FCF Ratio | 66.37 |
| P/OCF Ratio | 55.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.47, with an EV/FCF ratio of 66.67.
| EV / Earnings | 25.88 |
| EV / Sales | 4.14 |
| EV / EBITDA | 18.47 |
| EV / EBIT | 19.44 |
| EV / FCF | 66.67 |
Financial Position
The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.24.
| Current Ratio | 2.71 |
| Quick Ratio | 1.93 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.87 |
| Debt / FCF | 3.12 |
| Interest Coverage | 126.34 |
Financial Efficiency
Return on equity (ROE) is 21.50% and return on invested capital (ROIC) is 19.47%.
| Return on Equity (ROE) | 21.50% |
| Return on Assets (ROA) | 11.22% |
| Return on Invested Capital (ROIC) | 19.47% |
| Return on Capital Employed (ROCE) | 24.46% |
| Weighted Average Cost of Capital (WACC) | 10.63% |
| Revenue Per Employee | 66.79M |
| Profits Per Employee | 10.68M |
| Employee Count | 2,660 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 5.48 |
Taxes
In the past 12 months, Organo has paid 9.91 billion in taxes.
| Income Tax | 9.91B |
| Effective Tax Rate | 25.86% |
Stock Price Statistics
The stock price has increased by +105.89% in the last 52 weeks. The beta is 1.24, so Organo's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +105.89% |
| 50-Day Moving Average | 15,810.50 |
| 200-Day Moving Average | 13,907.50 |
| Relative Strength Index (RSI) | 44.07 |
| Average Volume (20 Days) | 285,205 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Organo had revenue of JPY 177.65 billion and earned 28.40 billion in profits. Earnings per share was 617.73.
| Revenue | 177.65B |
| Gross Profit | 65.08B |
| Operating Income | 37.65B |
| Pretax Income | 38.31B |
| Net Income | 28.40B |
| EBITDA | 39.63B |
| EBIT | 37.65B |
| Earnings Per Share (EPS) | 617.73 |
Balance Sheet
The company has 31.06 billion in cash and 34.40 billion in debt, with a net cash position of -3.35 billion or -72.79 per share.
| Cash & Cash Equivalents | 31.06B |
| Total Debt | 34.40B |
| Net Cash | -3.35B |
| Net Cash Per Share | -72.79 |
| Equity (Book Value) | 142.96B |
| Book Value Per Share | 3,109.10 |
| Working Capital | 121.06B |
Cash Flow
In the last 12 months, operating cash flow was 13.10 billion and capital expenditures -2.07 billion, giving a free cash flow of 11.03 billion.
| Operating Cash Flow | 13.10B |
| Capital Expenditures | -2.07B |
| Depreciation & Amortization | 1.98B |
| Net Borrowing | 11.82B |
| Free Cash Flow | 11.03B |
| FCF Per Share | 239.81 |
Margins
Gross margin is 36.64%, with operating and profit margins of 21.19% and 15.99%.
| Gross Margin | 36.64% |
| Operating Margin | 21.19% |
| Pretax Margin | 21.56% |
| Profit Margin | 15.99% |
| EBITDA Margin | 22.31% |
| EBIT Margin | 21.19% |
| FCF Margin | 6.21% |
Dividends & Yields
This stock pays an annual dividend of 190.00, which amounts to a dividend yield of 1.17%.
| Dividend Per Share | 190.00 |
| Dividend Yield | 1.17% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 29.81% |
| Buyback Yield | -0.02% |
| Shareholder Yield | 1.12% |
| Earnings Yield | 3.88% |
| FCF Yield | 1.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 29, 2022. It was a forward split with a ratio of 4.
| Last Split Date | Sep 29, 2022 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Organo has an Altman Z-Score of 6.6 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.6 |
| Piotroski F-Score | 5 |